Image de couverture de The Worried Well

The Worried Well

The Depression Epidemic and the Medicalisation of Our Sorrows

Écouter un extrait
La meilleure offre de la saison

0,99 €/mois pendant 3 mois + 15 € de crédit Audible

Renouvellement automatique à 6,99 €/mois après 3 mois. Annulation mensuelle possible.
Profiter de l’offre
L'offre prend fin le 28 décembre 2026.
Plus d'offres

The Worried Well

De : Gail Bell
Lu par : Marie-Louise Walker
Profiter de l’offre

Renouvellement automatique à 6,99 €/mois après 3 mois. Annulation mensuelle possible. L'offre se termine le 28 décembre 2026.

Acheter pour 15,95 €

Acheter pour 15,95 €

La meilleure offre de la saison | 0,99 €/mois pendant les 3 premiers mois + 15 € de crédit Audible

6,99 €/mois par la suite. Des conditions s’appliquent. Annulation mensuelle possible.
À propos de ce titre
In the second Quarterly Essay of 2005, Gail Bell investigates Australia's depression epidemic. Why, she wonders, do well over a million Australians now take antidepressant drugs? This is a fresh, frank and independent look at the depression culture and the move to medicalise sadness. Bell examines how the prescription culture operates, scrutinising the role of big drug companies and GPs and talking to those who take - and don't take - the new antidepressants, from anxious students to lonely retirees. She finds that drug companies have invested billions in an effort to simplify a profoundly complex mental condition, and that along the way ordinary problems of living have been transformed into medical conditions. She also finds that we, the consumers, have been happy to get on board: the vocabulary of depression - "serotonin", "bipolar", "genetic predisposition" - rolls off our tongues as if each of us had studied it at medical school. In this freeranging and elegant essay, Bell takes the pulse of Australia's "worried well" and looks at alternative cures for what ails us.©2005 Gail Bell (P)2012 Bolinda Publishing Seelische & Geistige Gesundheit
adbl_web_anon_alc_button_suppression_t1
Aucune critique pour le moment